Unlock instant, AI-driven research and patent intelligence for your innovation.

A method for detecting aspirin content in blood plasma and a pretreatment kit

A medium aspirin and pretreatment technology, applied in the direction of measuring devices, instruments, scientific instruments, etc., can solve the problems of complex sample pretreatment process, quantitative limit and precision not reaching the expected effect, low recovery rate, etc., and achieve easy clinical promotion Popularization, avoiding underdose, high accuracy effect

Active Publication Date: 2020-11-13
JINAN YING SHENG BIOTECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the inventors of the present invention have found that the existing liquid chromatography-mass spectrometry (LC-MS) method for detecting aspirin concentration in plasma adopts a single quadrupole mass spectrometer, and the sample pretreatment process is very complicated, and the recovery rate is low. Low, quantitative limit and precision and other indicators did not meet the expected results

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for detecting aspirin content in blood plasma and a pretreatment kit
  • A method for detecting aspirin content in blood plasma and a pretreatment kit
  • A method for detecting aspirin content in blood plasma and a pretreatment kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Internal standard working solution (1) Preparation of

[0045] Take concentration 50μg / mL internal standard aspirin (aspirin -D4) 80μL was added to 4mL of methanol, mixed, final concentration of 1000ng / mL, as an internal standard working solution for use.

[0046] (2) Preparation of working solution Calibrator

[0047] Formulated with methanol 100μg / mL stock solution of aspirin, then six gradient prepared with blank plasma concentrations of 5000,2500,1250,625,312.5,156ng / mL, the working fluid as calibrators, take 300μL aliquots frozen in 1.5mL dry flask, placed in a freeze drier, after pre-freezing -55 ℃ Ramp 4h then, for the first time from the vacuum heating, heating facilitate sublimation process, can accelerate the drying rate, the dry powder prepared in -20 ℃ stored for use. In use, removed from the refrigerator and placed at room temperature for 15-20 min balance, and then were added 300μL of pure water, mixing spare.

[0048] (3) Preparation of solution quali...

Embodiment 2

[0065] (1) The lower limit of quantification

[0066] The SNR ≧ 10, when the repetitive Cv≤20%, accuracy 15% deviation as a quantitative index of the lower limit of determination standard, add aspirin 0.5ng / mL when the blank plasma, the test was repeated 10 times, sample preparation and after detecting machine, data analysis can meet the above criteria.

[0067] (2) Precision

[0068]Three horizontal controls and patients who took aspirin drugs were repeated 10 times, and 30 days were detected, 30 test data were obtained, and the repeatability CV was calculated, and the results were 2.2-5.4%.

[0069] (3) recovery rate

[0070] Add the same volume of different concentrations of aspirin standard solutions to blank plasma, so that the final concentration is 200, 500, 1000 ng / ml, respectively, and each concentration is repeatedly tested 3 times, and the three mean values ​​are compared to the theoretical value, calculate the recovery rate, The result was 96 ± 3.1%.

[0071] (4) S...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for detecting aspirin content in blood plasma and a pretreatment kit, the method comprises a pretreatment process of a blood plasma sample, a calibration sample and / ora quality control sample, and LC-MS / MS detection is carried out on the pretreated sample; the pretreatment process comprises the following steps: adding the sample into an extraction plate, standingfor adsorption, and eluting with an eluent which is an ethyl acetate solution containing formic acid and oxalic acid. According to the method, aspirin in blood plasma can be accurately and quantitatively detected.

Description

Technical field [0001] The present invention belongs to the field of detection of aspirin content, it relates to a method and kit for the plasma pretreatment of detection of aspirin. Background technique [0002] The information disclosed in the background is disclosed only to increase the understanding of the overall background of the present invention, and is not necessarily considered to admit or imply that the information is intended to be a prior art known to those skilled in the art. [0003] Aspirin, also known as acetylsalicylic acid, commonly used anti-inflammatory drugs belonging to the clinical, clinical tests have been for many years, can relieve pain, such as headache, toothache, muscle pain, rheumatism and the like, the better. In recent years clinically useful in the treatment and prevention of cerebral infarction, myocardial infarction, thrombosis and other commonly used drugs to prevent cardiovascular diseases. According to statistics, my country's annual death t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N30/06G01N30/88
CPCG01N30/06G01N30/88
Inventor 冯振景叶松弭兆元
Owner JINAN YING SHENG BIOTECH